Literature DB >> 178978

Somatostatin inhibition of insulin secretion in insulin-producing tumors.

L A Scuro, V Lo Cascio, S Adami, G Galvanini, I Bianchi, L Cominacini, A Corgnati.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 178978     DOI： 10.1016/0026-0495(76)90056-1

Source DB:  PubMed          Journal:  Metabolism        ISSN： 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  8 in total

1.  Effects of somatostatin on insulin and glucagon in patients with insulinoma.

Authors:  F Fallucca; C Mirabella; G Tamburrano; S Gambardella; G Aufieri; F Barbetti; D Andreani
Journal:  J Endocrinol Invest       Date:  1979 Jul-Sep       Impact factor: 4.256

2.  The hyperinsulinaemic hypoglycaemias in infancy: a study of six cases.

Authors:  P Amendt; K D Kohnert; J Kunz
Journal:  Eur J Pediatr       Date:  1988-11       Impact factor: 3.183

3.  Effects of somatostatin in a case of severe hypoglycemia due to nesidioblastosis.

Authors:  E Roti; C Ghinelli; P Bandini; C Del Rossi; R Emanuele; G Robuschi; A Gnudi
Journal:  J Endocrinol Invest       Date:  1981 Apr-Jun       Impact factor: 4.256

4.  Gastroenteropancreatic endocrine tumors.

Authors:  C Weil
Journal:  Klin Wochenschr       Date:  1985-05-15

Review 5.  [Islet cell cancer with organic hyperinsulinism. Clinical aspects, diagnosis and therapy].

Authors:  R Wirsching; F Spelsberg; R Landgraf
Journal:  Klin Wochenschr       Date:  1982-08-16

6.  Inhibition of growth of pancreatic carcinomas in animal models by analogs of hypothalamic hormones.

Authors:  T W Redding; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

7.  Differentiation of insulin secretion patterns in insulinoma.

Authors:  Christiane Saddig; Peter E Goretzki; Achim A R Starke
Journal:  World J Surg       Date:  2008-05       Impact factor: 3.352

Review 8.  Somatostatin analogues for the treatment of hyperinsulinaemic hypoglycaemia.

Authors:  Basma Haris; Saras Saraswathi; Khalid Hussain
Journal:  Ther Adv Endocrinol Metab       Date:  2020-12-02       Impact factor: 3.565
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.